To analyze the impact of the dose to the optic disc and the irradiated length of the optic nerve on radiation-induced optic neuropathy, radiation-induced retinopathy, iris neovascularization, secondary glaucoma, enucleation, and local tumor control after proton beam therapy (PBT) of choroidal melanoma.
Retrospective analysis of 1129 patients, who received primary PBT for the treatment of choroidal melanoma with a dose of 60 cobalt gray equivalents (CGE) between 1998 and 2013 at the Helmholtz-Zentrum Berlin, Germany. Kaplan-Meier curves and logrank test have been used for time-to-event analyses. Adjustment for potential confounders was done using multiple Cox regression models with forward and backward selection.
We found a significant correlation between the irradiated length of the optic nerve and the dose to the optic disc (correlation coefficient, 0.93). Multivariate Cox regression revealed the dose to the optic disc as an independent predictive risk factor for the development of radiation-induced optic neuropathy (p < 0.001, HR 1.023, 95 CI 1.016–1.029), iris neovascularization (p < 0.001, HR 1.013, 95% CI 1.008–1.019), secondary glaucoma (p < 0.001, HR 1.017, 95% CI: 1.011-1.023) and enucleation (p < 0.001, HR 1.037, 95% CI 1.020-1.053). The irradiated length of the optic nerve was not a statistically independent predictive risk factor in multivariate analysis.
Our data implicate the predominance of the dose to the optic disc over the irradiated length of the optic nerve regarding radiation-induced optic neuropathy, iris neovascularization, secondary glaucoma, and enucleation.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Damato B (2012) Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye (Lond) 26:1157–1172. https://doi.org/10.1038/eye.2012.126
Riechardt AI, Cordini D, Willerding G, Georgieva I, Weber A, Seibel I, Lakotka N, Bechrakis NE, Foerster MH, Moser L, Joussen AM (2014) Proton beam therapy of parapapillary choroidal melanoma. Am J Ophthalmol 157:1258–1265
Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH (2013) Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters. Int J Radiat Oncol Biol Phys 87:330–336
Seibel I, Cordini D, Hager A, Tillner J, Riechardt AI, Heufelder J, Davids AM, Rehak M, Joussen AM (2016) Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 254:1787–1792
Akbaba S, Foerster R, Nicolay NH, Arians N, Bostel T, Debus J, Hauswald H (2018) Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma. Radiat Oncol 13:140
Somani S, Sahgal A, Krema H, Heydarian M, McGowan H, Payne D, Xu W, Michaels H, Laperriere N, Simpson ER (2009) Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: 2-year follow-up. Can J Ophthalmol 44:61–65. https://doi.org/10.3129/i08-177
Siedlecki J, Reiterer V, Leicht S, Foerster P, Kortüm K, Schaller U, Priglinger S, Fuerweger C, Muacevic A, Eibl-Lindner K (2017) Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy. Acta Ophthalmol 95:e734–e739. https://doi.org/10.1111/aos.13418
Yazici G, Kiratli H, Ozyigit G, Sari SY, Cengiz M, Tarlan B, Mocan BO, Zorlu F (2017) Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 98:152–158. https://doi.org/10.1016/j.ijrobp.2017.02.017
Eibl-Lindner K, Fürweger C, Nentwich M, Foerster P, Wowra B, Schaller U, Muacevic A (2016) Robotic radiosurgery for the treatment of medium and large uveal melanoma. Melanoma Res 26:51–57. https://doi.org/10.1097/CMR.0000000000000199
Krema H, Heydarian M, Beiki-Ardakani A, Weisbrod D, Xu W, Simpson ER, Sahgal A (2013) A comparison between 125Iodine brachytherapy and stereotactic radiotherapy in the management of juxtapapillary choroidal melanoma. Br J Ophthalmol 97:327–332
Maheshwari A, Finger PT (2018) A 12-year study of slotted palladium-103 plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve. Am J Ophthalmol 188:60–69. https://doi.org/10.1016/j.ajo.2018.01.025
Filì M, Trocme E, Bergman L, See TRO, André H, Bartuma K, Girnita L, All-Eriksson C, Seregard S, Stålhammar G (2020) Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm. Br J Ophthalmol 104:26–32
Goitein M, Miller T (1983) Planning proton therapy of the eye. Med Phys 10:275–283
Denker A, Cordini D, Heufelder J, Homeyer H, Kluge H, Simiantonakis I, Stark R, Weber A (2007) Ion accelerator applications in medicine and cultural heritage. Nucl Instrum Methods Phys Res A 580:457–461
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK American Joint Committee on Cancer (eds) et al (2017) AJCC Cancer Staging Manual, EightEdition, Springer, New York
Riechardt AI, Pilger D, Cordini D, Seibel I, Gundlach E, Hager A, Joussen AM (2017) Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors. Graefes Arch Clin Exp Ophthalmol 255:2263–2269. https://doi.org/10.1007/s00417-017-3737-3
Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL (2018) Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review. Brachytherapy 17:981–989
Nürnberg D, Seibel I, Riechardt AI, Brockmann C, Zeitz O, Heufelder J, Joussen AM (2018) Multimodal imaging of the choroidal melanoma, with differential diagnosis, therapy (radiation planning) and follow-up [Article in German]. Klin Monatsbl Augenheilkd 235:1001–1002
Chowdhury MM, Dagash H, Pierro A (2007) A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg 94:145–161
Hrbacek J, Mishra KK, Kacperek A, Dendale R, Nauraye C, Auger M, Herault J, Daftari IK, Trofimov AV, Shih HA, Chen YL, Denker A, Heufelder J, Horwacik T, Swakoń J, Hoehr C, Duzenli C, Pica A, Goudjil F, Mazal A, Thariat J, Weber DC (2016) Practice patterns analysis of ocular proton therapy centers: the International OPTIC Survey. Int J Radiat Oncol Biol Phys 95:336–343. https://doi.org/10.1016/j.ijrobp.2016.01.040
Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J (2010) Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76:28–35
Zeisberg A, Seibel I, Cordini D, Lakotka N, Willerding G, Moser L, Heufelder J, Joussen AM (2014) Long-term (4 years) results of choroidal hemangioma treated with proton beam irradiation. Graefes Arch Clin Exp Ophthalmol 252:1165–1170. https://doi.org/10.1007/s00417-014-2635-1
Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, Goitein G (2001) Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 51:138–147
Conflict of interest
A.I. Riechardt: reimbursements of travel expense: EURETINA 2015/Novartis. A. Stroux, I. Seibel, J. Heufelder, O. Zeitz, D. Böhmer, A. M. Joussen, and J. Gollrad state that there are no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. This article does not contain any studies with animals performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Riechardt, A.I., Stroux, A., Seibel, I. et al. Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve. Graefes Arch Clin Exp Ophthalmol 258, 2523–2533 (2020). https://doi.org/10.1007/s00417-020-04780-y
- Choroidal melanoma
- Proton beam therapy
- Irradiated nerve length
- Dose to the optic disc
- Secondary glaucoma